Demand for dermal fillers in Europe market is set to grow by 4.5% from 2023 to 2033 with an estimated market value of around USD 1.63 Billion as of 2023. As per Future Market Insights, Hyaluronic Acid segment by ingredient type held a share of about 71.4% in 2022 within the European Market
Market Outlook:
Data Points | Market Insights |
---|---|
Europe Dermal Fillers Market Value 2022 | USD 1.57 Billion |
Market Value 2023 | USD 1.63 Billion |
Market Value 2033 | USD 2.52 Billion |
CAGR 2023 to 2033 | 4.5% |
Market Share of Top 3 Countries | 79.5% |
Dermal fillers have become more popular in the European market as a result of rising disposable incomes and a shift in customers' attitudes towards non-surgical methods of enhancing their aesthetic appeal. These treatments are in great demand among customers because of their high level of safety and acceptable patient results.
Due to new developments in rejuvenation and cosmetic enhancements that were previously only possible through surgery, dermal fillers have seen a sharp increase in popularity recently. Dermal fillers exhibit immediate benefits in cosmetic volume restoration procedures because to their less invasive nature.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Europe dermal fillers market recorded a historic CAGR of 2.7% in the last 10 years from 2012 to 2022. Europe dermal fillers market holds around 26.1% of the Global dermal fillers market in 2022.
The popularity of social media sites and the prominence of celebrities have raised public awareness of fashion and beauty trends. The amount of social media coverage of dermal fillers rose eightfold between 2010 and 2020. Digital messages are widely received by new patient groups; for instance, 60% of Twitter mentions are from men and people under the age of 25.
The endorsements and suggestions of many of these social influencers, who have large fan bases in Europe, affects people's tastes and decisions about cosmetic treatments like using dermal fillers. Platforms like Instagram are excellent for displaying aesthetic changes since they are very visual and image-focused.
The popularity of content featuring before-and-after images and behind-the-scenes peeks at cosmetic operations has increased people's interest in and curiosity about various aesthetic procedures. Hence Europe has seen a rising demand.
Manufacturers do the same thing by maintaining active social media profiles and websites where they provide before-and-after photos, success tales, and how-to guides.
By collaborating with suppliers and customers to develop cutting-edge products that will increase sales and profits for both parties, firms and manufacturers are expecting to increase their clientele. They employ an integrated approach to developing new products and processes by integrating a number of approaches into their operations.
Many companies have also formed strategic partnership with clinics and KOLs of the aesthetic industry in Europe, to promote their products and distribute the patients with the brochures of product benefits to boost the sales.
Overall, the growing popularity and promotion of dermal fillers have led to the rise in the demand in the European region.
The demand for non-invasive aesthetic procedures is increasing in Europe, which has created new business prospects for the producers of dermal fillers.
Dermal fillers are further becoming more popular in Europe as the population their ages and individuals look for ways to stay youthful. These fillers can treat volume loss, wrinkles, and sagging skin.
Dermal fillers have also demonstrated the potential to be employed in combination treatments for numerous applications. Apart from the popular application, anti-aging treatment, which has wonderful advantages, dermal fillers have a variety of other uses: The ability to mix dermal fillers with other procedures is one of its finest features. In fact, combining dermal fillers with Botox injections can produce the smoothest and natural results for face skin. Dermal fillers with Botox and Xeomin work best together to treat deeper and more pronounced wrinkles.
The customized solutions combined with the advanced formulations have led manufacturers develop marketing campaigns that resonate with different cultural preferences and age groups in different countries of Europe
The expensive procedures using dermal fillers for treating both basic and complex parts of the face and body have slowed the market's expansion. The cost of the doctor or surgeon is around 40 to 50 percent of the dermal filler price. Additionally, the whole therapy involves numerous sessions, which makes it more difficult to fund the treatment in main circumstances.
In major cases the effect of the dermal fillers is not very long lasting. With the exception of PMMA fillers, the dermal fillers that are now on the market are absorbable and biodegradable. Only 3 to 24 months are the life of these biodegradable fillers.
The estimated lifespan of PMMA fillings is 4 to 5 years. As a result, the process might be repeated after a specified amount of time. Few people choose surgical face rejuvenation over dermal fillers because of this, as the results persist a long time.
These factors can pose as a potential threat to the growth of the dermal fillers market in Europe.
Germany dominates the European market of dermal fillers with 33.3% market share in 2022 and is projected to continue experiencing high growth throughout the forecast period.
Germany boasts one of the prominent economies in Europe and one of the significant living standards. A sizeable percentage of the population can now afford cosmetic procedures like dermal fillers due to this wealth. In Germany, knowledge and acceptability of cosmetic operations have grown over the past several years. The demand for non-surgical cosmetic procedures like dermal fillers has surged as a result of this change in public attitudes.
Additionally, the technological advancements and well developed healthcare systems with efficient patient care and physicians have added to the market growth.
The United Kingdom holds about 12.0% of the market share, within Europe in 2022.
A strong culture of cosmetics and beauty exists in the United Kingdom. Dermal fillers and other cosmetic operations are becoming more widely accepted as ways to improve one's look and increase self-confidence. Celebrities, influencers, and social media are all very prevalent and have a big impact on how people see beauty.
Medical tourists from other nations come to the United Kingdom to receive top-notch medical care, including cosmetic surgeries. The market for dermal fillers is expanding as a result of this inflow of foreign patients.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Hyaluronic Acid segment within the ingredient segment hold a revenue share of 71.4% in 2022, and the same trend is being followed over the forecasted period.
Hyaluronic acid is extremely biocompatible since it is a naturally occurring component in the human body. This lowers the possibility of allergic responses or other negative consequences, making it a safe choice for the majority of people. Dermal fillers' main objective is to produce outcomes that seem natural. HA fillers create slight improvements without seeming unduly artificial since they blend in perfectly with the structure of the skin.
Absorbable dermal fillers held a market share of 99.9% in 2022. Dermal fillers that dissolve naturally provide effects. They enhance features without giving an unnatural look since they blend in naturally with the skin's tissue. The body's normal metabolic activities progressively degrade them over time. This progressive deterioration minimizes the possibility of abrupt and unwelcome changes in appearance while allowing for modifications or touch-ups when necessary.
Aesthetic Restoration within the application segment hold a market share of 82.2% in 2022, within the forecasted period.
Dermal filler techniques are frequently used in aesthetic restoration because to their efficiency in treating various ageing symptoms and improving natural characteristics. the benefits of skin replenishment by boosting these regions' look and reviving them overall are the major benefits. By boosting volume under the skin's surface, dermal fillers can effectively smooth out wrinkles, fine lines, and creases. This contributes to a smoother, younger-looking appearance.
Specialty Clinics within the distribution channel segment hold a market share of 86.5% in 2022, within the forecasted period.
Due to the increasing demand for dermal filler procedures, the customized treatment plans, collaborations with major filler brands the service of these specialty clines are the best and it in turn to attract more and more customers making it the hold the significant market share.
Key manufacturers of dermal filler brands are focusing on new improved product launches and collaborations with KOLs and clinics to promote their products.
Similarly, recent developments related to companies in Europe Dermal Fillers Market have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2012 to 2022 |
Market Analysis | USD Million for Value, Units for Volume |
Key Countries Covered | United Kingdom, Germany, Spain, Italy, France, BENELUX, Nordics, and Rest of Europe |
Key Market Segments Covered | Ingredient, Product, Application, Distribution Channel and Country |
Key Companies Profiled | Galderma Pharma S.A; Bioscience GmbH; Croman Pharma; Allergan plc. (AbbVie); Sinclair Pharma plc. (Heading Medicine Co., Ltd); Zimmer Aesthetics; Mars Pharma GmbH & Co. Kraal; Zueva Medical, Inc.; Texan Laboratories Inc.; Adder GmbH; Polonium Medical Technologies Inc.; Intracellular Medical UK Ltd; LKC Pharma; Biloxi’s Pharmaceutical |
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Pricing | Available upon Request |
The market is valued at USD 1.63 billion in 2023.
The market recorded a CAGR of 2.7% from 2018 to 2022.
The market is estimated to be worth USD 2.52 billion in 2033.
The hyaluronic acid held a market share of 71.4% in 2022.
The growing preference for non-invasive procedures is likely to provide a boost to the market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Europe Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033 7. Europe Market: Pricing Analysis 8. Europe Market Demand (in Value or Size in USD Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033 9. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product 9.1. Absorbable 9.2. Non - Absorbable 10. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Ingredient 10.1. Hyaluronic Acid 10.2. Poly-L-Lactic Acid 10.3. Calcium Hydroxylapatite 10.4. Polymethyl methacrylate 10.5. Collagen 10.6. Polynucleotide (PN) 11. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application 11.1. Aesthetic Restoration 11.2. Dentistry 11.3. Reconstructive Surgery 12. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel 12.1. Hospitals 12.2. Speciality Clinics 12.2.1. Small 12.2.2. Medium 12.2.3. Large 12.3. Online Pharmacies 13. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region 13.1. United Kingdom 13.2. Germany 13.3. France 13.4. Italy 13.5. Spain 13.6. BENELUX 13.7. Nordics 14. United Kingdom Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15. Germany Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16. Spain Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17. Italy Market Analysis 2012 to 2022 and Forecast 2023 to 2033 18. France Market Analysis 2012 to 2022 and Forecast 2023 to 2033 19. BENELUX Market Analysis 2012 to 2022 and Forecast 2023 to 2033 20. Nordics Market Analysis 2012 to 2022 and Forecast 2023 to 2033 21. Market Structure Analysis 22. Competition Analysis 22.1. Galderma SA 22.2. BioScience GmbH 22.3. Croma Pharma 22.4. Sinclair Pharma Plc. 22.5. Zimmer Aesthetics 22.6. Merz Pharma GmbH & Co. KgaA 22.7. Teoxane Laboratories Inc. 22.8. Adoderm GmbH 22.9. LKC Pharma 22.10. Celiraz Europe S.L. 22.11. Allergan plc. (AbbVie) 22.12. Suneva Medical, Inc 22.13. Prollenium Medical Technologies Inc. 22.14. Anika Therapeutics, Inc. 22.15. DR. Korman 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports